<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Antiphospholipids | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Antiphospholipid Antibody (aPL) Assays  Definition: A group of laboratory tests used to detect and measure the levels of antiphospholipid antibodies (aPL) in serum or plasma. aPLs are...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Antiphospholipids | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Antiphospholipid Antibody (aPL) Assays  Definition: A group of laboratory tests used to detect and measure the levels of antiphospholipid antibodies (aPL) in serum or plasma. aPLs are...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Antiphospholipids | Hematology">
<meta name="twitter:description" content="Overview of Antiphospholipid Antibody (aPL) Assays  Definition: A group of laboratory tests used to detect and measure the levels of antiphospholipid antibodies (aPL) in serum or plasma. aPLs are...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary-1.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="active" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Microbiology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="antiphospholipids" class="section level1 unnumbered">
<h1>Antiphospholipids<a class="anchor" aria-label="anchor" href="#antiphospholipids"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-antiphospholipid-antibody-apl-assays" class="section level2 unnumbered">
<h2>
<strong>Overview of Antiphospholipid Antibody (aPL) Assays</strong><a class="anchor" aria-label="anchor" href="#overview-of-antiphospholipid-antibody-apl-assays"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A group of laboratory tests used to detect and measure the levels of antiphospholipid antibodies (aPL) in serum or plasma. aPLs are autoantibodies directed against phospholipids and phospholipid-binding proteins, and their presence is associated with an increased risk of thrombosis and pregnancy morbidity</li>
<li>
<strong>Clinical Significance:</strong>
<ul>
<li>Diagnosis of Antiphospholipid Syndrome (APS): The presence of aPLs, along with specific clinical criteria (thrombosis or pregnancy morbidity), is used to diagnose APS</li>
<li>Risk Stratification: aPL titers and profiles can help assess the risk of thrombosis or pregnancy complications in individuals with APS</li>
<li>Evaluation of Unexplained Thrombosis or Pregnancy Loss: aPL testing is recommended in patients with unexplained venous or arterial thrombosis, recurrent pregnancy loss, or other clinical features suggestive of APS</li>
</ul>
</li>
<li>
<strong>Key Assays:</strong> The main aPL assays include:
<ul>
<li>Lupus Anticoagulant (LA) Testing</li>
<li>Anticardiolipin (aCL) Antibody Assay</li>
<li>Anti-β2 Glycoprotein I (anti-β2GPI) Antibody Assay</li>
</ul>
</li>
</ul>
</div>
<div id="key-concepts-target-antigens-and-antibody-isotypes" class="section level2 unnumbered">
<h2>
<strong>Key Concepts: Target Antigens and Antibody Isotypes</strong><a class="anchor" aria-label="anchor" href="#key-concepts-target-antigens-and-antibody-isotypes"><i class="fas fa-link"></i></a>
</h2>
<p>aPLs can target various phospholipid-binding proteins, with the most clinically relevant being:</p>
<ul>
<li>Cardiolipin (aCL): A negatively charged phospholipid found in cell membranes</li>
<li>β2-Glycoprotein I (β2GPI): A plasma protein that binds to negatively charged phospholipids</li>
<li>Antibody Isotypes: IgG, IgM, and IgA isotypes of aCL and anti-β2GPI antibodies are measured, with IgG isotypes generally having the strongest association with thrombosis and pregnancy morbidity</li>
</ul>
</div>
<div id="lupus-anticoagulant-la-testing-1" class="section level2 unnumbered">
<h2>
<strong>Lupus Anticoagulant (LA) Testing</strong><a class="anchor" aria-label="anchor" href="#lupus-anticoagulant-la-testing-1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Principle:</strong></p>
<ul>
<li>LA prolongs phospholipid-dependent clotting tests <em>in vitro</em> by interfering with the assembly of coagulation complexes on phospholipid surfaces</li>
<li>LA is not a true anticoagulant in vivo; it is associated with an increased risk of thrombosis</li>
</ul>
</li>
<li>
<p><strong>Testing Algorithm:</strong></p>
<ul>
<li>LA testing involves a series of tests to demonstrate:
<ul>
<li>Prolongation of phospholipid-dependent clotting tests (screening tests)</li>
<li>Failure to correct with mixing studies (presence of an inhibitor)</li>
<li>Correction with the addition of excess phospholipid (phospholipid dependence)</li>
</ul>
</li>
<li>Test Selection and Interpretation
<ul>
<li>Screening Test: Sensitive to the presence of LA</li>
<li>Mixing Study: In this process the addition of other test subjects will not correct issues from being outside. If it doesn’t correct, an inhibitor is present</li>
<li>Confirmatory Test: To confirm if phospholipid is present when performing a hexagonal phase</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Confirmatory Tests:</strong></p>
<ul>
<li>Dilute Russell’s Viper Venom Time (dRVVT)</li>
<li>Silica Clotting Time (SCT)</li>
<li>Hexagonal Phase Phospholipid Neutralization Assay</li>
</ul>
</li>
<li>
<p><strong>Interpretation:</strong></p>
<ul>
<li>Prolonged Screening Test: Suggests the presence of an inhibitor</li>
<li>Failure to Correct on Mixing: Confirms the presence of an inhibitor</li>
<li>Phospholipid Dependence: Correction with excess phospholipid confirms that the inhibitor is a lupus anticoagulant</li>
<li>Requires Persistent Positivity: To meet the laboratory criteria for APS, the LA must be present on two or more occasions, at least 12 weeks apart</li>
</ul>
</li>
</ul>
</div>
<div id="anticardiolipin-acl-antibody-assay" class="section level2 unnumbered">
<h2>
<strong>Anticardiolipin (aCL) Antibody Assay</strong><a class="anchor" aria-label="anchor" href="#anticardiolipin-acl-antibody-assay"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Principle:</strong></p>
<ul>
<li>An ELISA-based assay that measures the levels of IgG and/or IgM antibodies that bind to cardiolipin, a negatively charged phospholipid</li>
</ul>
</li>
<li>
<p><strong>Procedure:</strong></p>
<ol style="list-style-type: decimal">
<li>Microplate Wells Coated with Cardiolipin</li>
<li>Patient Sample is added to determine what happens with lipid testing.</li>
<li>An enzyme-labeled secondary antibody (e.g., anti-human IgG or anti-human IgM) is added to determine anti-cardiolipin antibodies.</li>
<li>A substrate is used to detect the anti-cardiolipin, and light passes through to help determine.</li>
</ol>
</li>
<li>
<p><strong>Reporting:</strong></p>
<ul>
<li>Results are reported in GPL units (for IgG aCL) or MPL units (for IgM aCL)</li>
<li>Reported as negative, low positive, medium positive, or high positive based on established cut-off values:
<ul>
<li>Negative: &lt;20 GPL or MPL units</li>
<li>Low Positive: 20-39 GPL or MPL units</li>
<li>Medium Positive: 40-79 GPL or MPL units</li>
<li>High Positive: ≥80 GPL or MPL units</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Interpretation:</strong></p>
<ul>
<li>Elevated aCL Levels: Suggests the presence of aCL antibodies</li>
<li>Requires Persistent Positivity: To meet the laboratory criteria for APS, the aCL antibodies must be present on two or more occasions, at least 12 weeks apart</li>
<li>Clinical Significance:
<ul>
<li>High titers of IgG aCL antibodies are more strongly associated with thrombosis and pregnancy morbidity</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="anti-β2-glycoprotein-i-anti-β2gpi-antibody-assay" class="section level2 unnumbered">
<h2>
<strong>Anti-β2 Glycoprotein I (anti-β2GPI) Antibody Assay</strong><a class="anchor" aria-label="anchor" href="#anti-%CE%B22-glycoprotein-i-anti-%CE%B22gpi-antibody-assay"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Principle:</strong></p>
<ul>
<li>An ELISA-based assay that measures the levels of IgG and/or IgM antibodies that bind to β2-glycoprotein I, a plasma protein that binds to negatively charged phospholipids</li>
</ul>
</li>
<li>
<p><strong>Procedure:</strong></p>
<ol style="list-style-type: decimal">
<li>Microplate wells coated with Beta-2-Glycoprotein is mixed with the plasma.</li>
<li>An enzyme-labeled secondary antibody (e.g., anti-human IgG or anti-human IgM) is added to each well to determine.</li>
<li>If positive, this will result in the enzyme causing an increased signal.</li>
</ol>
</li>
<li>
<p><strong>Reporting:</strong></p>
<ul>
<li>Results are reported in units/mL or arbitrary units (AU/mL)</li>
<li>Reported as negative, low positive, medium positive, or high positive based on established cut-off values:
<ul>
<li>Negative: &lt;20 units/mL</li>
<li>Low Positive: 20-39 units/mL</li>
<li>Medium Positive: 40-79 units/mL</li>
<li>High Positive: ≥80 units/mL</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Interpretation:</strong></p>
<ul>
<li>Elevated anti-β2GPI Levels: Suggests the presence of anti-β2GPI antibodies</li>
<li>Requires Persistent Positivity: To meet the laboratory criteria for APS, the anti-β2GPI antibodies must be present on two or more occasions, at least 12 weeks apart</li>
<li>Clinical Significance:
<ul>
<li>High titers of IgG anti-β2GPI antibodies are more strongly associated with thrombosis and pregnancy morbidity</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="general-factors-affecting-apl-assay-results" class="section level2 unnumbered">
<h2>
<strong>General Factors Affecting aPL Assay Results</strong><a class="anchor" aria-label="anchor" href="#general-factors-affecting-apl-assay-results"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Pre-Analytical Variables:</strong></p>
<ul>
<li>Improper Collection Technique: May activate coagulation factors and affect results</li>
<li>Incorrect Blood-to-Anticoagulant Ratio: Underfilling or overfilling the collection tube</li>
<li>Clotted Sample: Invalidates the results</li>
<li>Delayed Testing: aPLs can degrade over time</li>
<li>Improper Storage: Incorrect storage temperatures can affect results</li>
</ul>
</li>
<li>
<p><strong>Analytical Variables:</strong></p>
<ul>
<li>Reagent Quality: Use fresh, properly stored reagents, and follow the manufacturer’s instructions</li>
<li>Instrument Calibration: Ensure proper calibration and maintenance of the instruments</li>
<li>Interfering Substances: High levels of lipids, bilirubin, or paraproteins can interfere with ELISA-based assays</li>
</ul>
</li>
<li>
<p><strong>Patient-Related Variables:</strong></p>
<ul>
<li>Medications: Warfarin, heparin, direct oral anticoagulants, and other medications can affect coagulation test results</li>
<li>Acute Thrombotic Events: May consume coagulation factors and aPLs, leading to falsely negative results</li>
<li>Infections: Transiently elevated aPL levels can be seen in some infections</li>
<li>Autoimmune Disorders: The presence of other autoimmune antibodies (e.g., antinuclear antibodies) can affect aPL results</li>
</ul>
</li>
</ul>
</div>
<div id="troubleshooting-erroneous-results-13" class="section level2 unnumbered">
<h2>
<strong>Troubleshooting Erroneous Results</strong><a class="anchor" aria-label="anchor" href="#troubleshooting-erroneous-results-13"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p>If the aPL assay results are unexpected or inconsistent with the patient’s clinical presentation:</p>
<ul>
<li>Check the sample for clots or hemolysis</li>
<li>Repeat the test on a fresh sample</li>
<li>Ensure that the correct blood-to-anticoagulant ratio was used</li>
<li>Verify the instrument and reagent quality control results</li>
<li>Investigate potential interfering substances</li>
<li>Review the patient’s medication list and medical history</li>
<li>Ensure that the aPLs have been positive on two or more occasions, at least 12 weeks apart</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-99" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-99"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Antiphospholipid Antibodies (aPL):</strong> Autoantibodies directed against phospholipids and phospholipid-binding proteins</li>
<li>
<strong>Lupus Anticoagulant (LA):</strong> An antibody that interferes with phospholipid-dependent coagulation assays in vitro and is associated with thrombosis in vivo</li>
<li>
<strong>Anticardiolipin (aCL) Antibodies:</strong> Antibodies that bind to cardiolipin, a negatively charged phospholipid</li>
<li>
<strong>Anti-β2 Glycoprotein I (anti-β2GPI) Antibodies:</strong> Antibodies that bind to β2-glycoprotein I, a plasma protein that binds to phospholipids</li>
<li>
<strong>Antiphospholipid Syndrome (APS):</strong> An autoimmune disorder characterized by thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies</li>
<li>
<strong>ELISA:</strong> Enzyme-Linked Immunosorbent Assay, a common type of immunoassay</li>
<li>
<strong>Thrombosis:</strong> Formation of a blood clot inside a blood vessel</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? l.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="assays.html">Assays</a></div>
<div class="next"><a href="protein-c.html">Protein C</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#antiphospholipids">Antiphospholipids</a></li>
<li><a class="nav-link" href="#overview-of-antiphospholipid-antibody-apl-assays">Overview of Antiphospholipid Antibody (aPL) Assays</a></li>
<li><a class="nav-link" href="#key-concepts-target-antigens-and-antibody-isotypes">Key Concepts: Target Antigens and Antibody Isotypes</a></li>
<li><a class="nav-link" href="#lupus-anticoagulant-la-testing-1">Lupus Anticoagulant (LA) Testing</a></li>
<li><a class="nav-link" href="#anticardiolipin-acl-antibody-assay">Anticardiolipin (aCL) Antibody Assay</a></li>
<li><a class="nav-link" href="#anti-%CE%B22-glycoprotein-i-anti-%CE%B22gpi-antibody-assay">Anti-β2 Glycoprotein I (anti-β2GPI) Antibody Assay</a></li>
<li><a class="nav-link" href="#general-factors-affecting-apl-assay-results">General Factors Affecting aPL Assay Results</a></li>
<li><a class="nav-link" href="#troubleshooting-erroneous-results-13">Troubleshooting Erroneous Results</a></li>
<li><a class="nav-link" href="#key-terms-99">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Microbiology/blob/blob/main/Rmd/05-27-hemostasis-laboratory-hypercoagulability-assays-aps.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Microbiology/blob/edit/main/Rmd/05-27-hemostasis-laboratory-hypercoagulability-assays-aps.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->


</body>
</html>
